Literature DB >> 216265

Retinal aneurysms in adult cytomegalovirus retinitis.

J J Augsburger, R Y Henry.   

Abstract

We observed aneurysms of the retinal arteries, capillaries, and venules occurring in a patient with cytomegalovirus retinitis. These aneurysms were caused by involvement of the retinal vascular endothelium resulting in focal weaknesses in the vascular walls. The clinical appearance of this retinitis superficially resembled retinal branch vein occlusion.

Entities:  

Mesh：

Year:  1978        PMID： 216265     DOI： 10.1016/0002-9394(78)90123-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


  5 in total

1.  Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).

Authors:  J Orellana; S A Teich; J S Winterkorn; U Mathur-Wagh; S Handwerger; H Schlamm; S C Malamud; S R Yancovitz; D M Cederberg; D S Mildvan
Journal:  Br J Ophthalmol       Date:  1988-07       Impact factor: 4.638

2.  Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.

Authors:  W J Waldman; D A Knight
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

3.  Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells.

Authors:  W J Waldman; W H Roberts; D H Davis; M V Williams; D D Sedmak; R E Stephens
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Alteration of the blood-retina barriers in cases of viral retinitis.

Authors:  B Kovács
Journal:  Int Ophthalmol       Date:  1985-09       Impact factor: 2.031

5.  Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS).

Authors:  A H Friedman; J Orellana; W R Freeman; M H Luntz; M B Starr; M L Tapper; I Spigland; H Roterdam; R Mesa Tejada; S Braunhut; D Mildvan; U Mathur
Journal:  Br J Ophthalmol       Date:  1983-06       Impact factor: 4.638
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.